Targeting the metabolic vulnerability of acute myeloid leukemia blasts with a combination of venetoclax and 8-chloro-adenosine

被引：0
|
作者：
Ralf Buettner
Le Xuan Truong Nguyen
Corey Morales
Min-Hsuan Chen
Xiwei Wu
Lisa S. Chen
Dinh Hoa Hoang
Servando Hernandez Vargas
Vinod Pullarkat
Varsha Gandhi
Guido Marcucci
Steven T. Rosen
机构：
[1] City of Hope Medical Center,Hematology Malignancies Research Institute, Gehr Family Center for Leukemia Research
[2] City of Hope Medical Center,Integrative Genomics Core, Beckman Research Institute
[3] The University of Texas MD Anderson Cancer Center,Department of Experimental Therapeutics
来源：
Journal of Hematology & Oncology | / 14卷
关键词：
Acute myeloid leukemia; Oxidative phosphorylation; Fatty acid oxidation; Nucleoside analog; Metabolism;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [11] Azacitidine in combination with shortened venetoclax treatment cycles in patients with acute myeloid leukemia
    Fleischmann, Maximilian
    Jentzsch, Madlen
    Brioli, Annamaria
    Eisele, Florian
    Frietsch, Jochen J.
    Eigendorff, Farina
    Tober, Romy
    Schrenk, Karin G.
    Hammersen, Jakob Friedrich
    Yomade, Olaposi
    Hilgendorf, Inken
    Hochhaus, Andreas
    Scholl, Sebastian
    Schnetzke, Ulf
    ANNALS OF HEMATOLOGY, 2025, 104 (01) : 285 - 294
  • [12] Chidamide in Combination With DCAG With or Without Venetoclax for Relapsed/Refractory Acute Myeloid Leukemia
    Liu, Qingyang
    Zhang, Xiawei
    Lv, Lei
    Xu, Linming
    Jing, Yu
    Gao, Wenjing
    Wang, Lili
    Dou, Liping
    CANCER MEDICINE, 2025, 14 (05):
  • [13] Venetoclax Combination Treatment of Acute Myeloid Leukemia in Adolescents and Young Adult Patients
    Chatzikalil, Elena
    Roka, Kleoniki
    Diamantopoulos, Panagiotis T.
    Rigatou, Efthymia
    Avgerinou, Georgia
    Kattamis, Antonis
    Solomou, Elena E.
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (07)
  • [14] Limited efficacy of Venetoclax Combination Regimens in Acute Myeloid Leukemia with Extramedullary Relapse
    Bae, Soyoung
    Sa, Seungwon
    Park, Silvia
    Cho, Byung-Sik
    Kim, Hee-Je
    ACTA HAEMATOLOGICA, 2023, : 352 - 359
  • [15] Decitabine in Combination with Venetoclax in Six Elderly Patients with Acute Myeloid Leukemia (AML)
    Rios, Adan
    Kanaan, Zeyad
    Nghia Nguyen
    Rekoff, Gregg
    Chen, Lei
    Wahed, Amer
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S211 - S211
  • [16] Repurposing ribosome-targeting antibiotics to overcome resistance to venetoclax in acute myeloid leukemia
    Sharon, David
    Chan, Steven M.
    MOLECULAR & CELLULAR ONCOLOGY, 2020, 7 (02)
  • [17] Venetoclax Overcomes Sorafenib Resistance in Acute Myeloid Leukemia by Targeting BCL2
    Xu, Xi
    Ma, Weiwei
    Qiu, Guo
    Xuan, Li
    He, Chong
    Zhang, Tian
    Wang, Jian
    Liu, Qifa
    BIOLOGY-BASEL, 2023, 12 (10):
  • [18] Venetoclax combination therapy in relapsed/refractory acute myeloid leukemia: A single institution experience
    Gaut, Daria
    Burkenroad, Aaron
    Duong, Tuyen
    Feammelli, Jesse
    Sasine, Joshua
    Schiller, Gary
    LEUKEMIA RESEARCH, 2020, 90
  • [19] Targeting metabolic vulnerabilities to overcome resistance to therapy in acute myeloid leukemia
    Sharma, Priyanka
    Borthakur, Gautam
    CANCER DRUG RESISTANCE, 2023, 6 (03) : 567 - 589
  • [20] Targeting of G3BP2 Refines Prognosis and Synergizes with Venetoclax in Acute Myeloid Leukemia
    Chen, Zhixiang
    Cai, Yuanhua
    Lai, Xiaolin
    Li, Xiaofan
    Pan, Lili
    Wang, Xuechun
    Tu, Fuquan
    Ye, Luya
    Li, Yang
    Wang, Shaoyuan
    BLOOD, 2022, 140 : 11494 - 11495
12345